Skip to content

Effect of Cocoa Supplementation in Training Athletes Microbiota and Metabolome

Effect of Cocoa Supplementation in Training Athletes Microbiota and Metabolome: Effects on Acute and Adaptive Exercise

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04444388
Enrollment
40
Registered
2020-06-23
Start date
2020-07-01
Completion date
2020-10-01
Last updated
2020-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Athletes

Brief summary

It has recently been suggested that cocoa may improve exercise performance and recovery. This study aim to evaluate the plasma and fecal metabolome after 10 weeks of cocoa supplementation during the training period in recreational athletes to detect possible metabolites involved in the observed benefits of cocoa in athletes

Interventions

DIETARY_SUPPLEMENTcocoa

Sachets of 5 grams of cocoa daily supplementation

DIETARY_SUPPLEMENTPlacebo

Sachets of 5 grams of maltodextrin daily supplementation

Sponsors

Universidad Europea de Madrid
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-45 years of age * high physical condition (VO2 ≥ 55 ml/kg/min) * BMI 18-25 kg/m2

Exclusion criteria

* antibiotics intake during 3 months prior to the study, * smoking * nutritional complements * ergogenic complements * prebiotics * probiotics * vegetarian or vegan diet * chronic medication * gastrointestinal surgery * Any diagnosed disease

Design outcomes

Primary

MeasureTime frameDescription
Fecal microbiotaChanges from baseline to 10 weeks of interventionAbundance of bacterial taxa determined by 16SRNAr gene sequencing
Fecal metabolome profileChanges from baseline to 10 weeks of interventionAbundance of fecal metabolites, metabolic networks, and metabolic pathways determined by High Pressure Liquid Chromatography-Mass Spectrometry
Plasma metabolome profileChanges from baseline to 10 weeks of interventionAbundance of blood metabolites, metabolic networks, and metabolic pathways activity determined by High Pressure Liquid Chromatography-Mass Spectrometry

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026